Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2023-03-02 Director's Dealing
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
Oxurion Receives Transparency Notification from Negma Group .pdf
Director's Dealing Classification · 98% confidence The document is a press release announcing that Oxurion NV received a 'transparency notification' from Negma Group Ltd. The notification details that Negma Group crossed a major shareholding threshold (3%) due to the acquisition of voting securities, as required by Belgian Transparency legislation. This type of filing specifically concerns changes in significant share ownership levels crossing regulatory thresholds. This directly matches the definition for Major Shareholding Notification (MRQ). It is not an Earnings Release (ER), Annual Report (10-K), or a Director's Dealing (DIRS), as it concerns a major shareholder, not necessarily a director, and is a notification of the holding change itself.
2023-03-02 English
oxur-transparency-notification-nl-2023-3-02-final.pdf
Major Shareholding Notification Classification · 98% confidence The document is a press release titled "Oxurion ontvangt transparantiekennisgeving van Negma Group" (Oxurion receives transparency notification from Negma Group). It explicitly states that Oxurion received a transparency notification from Negma Group in accordance with Belgian transparency legislation regarding the crossing of a voting rights threshold (3%) due to the acquisition of new shares. The attached appendix (BIJLAGE 1) is a Form TR-1 BE (Transparency notification) filed with the FSMA, detailing the acquisition of voting rights by Negma Group Ltd. This type of filing, which reports changes in significant share ownership crossing regulatory thresholds, directly corresponds to the Major Shareholding Notification category.
2023-03-02 Dutch
Oxurion Announces Subscription Agreement with Atlas Providing the Company with Up To €20 Million in Funding.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing a new subscription agreement for convertible bonds with Atlas Special Opportunities, LLC, providing up to €20 million in financing, and an amendment to an existing debt agreement. This falls under the category of capital raising and financing activities. While there is an attachment link at the end, the document itself provides the full details of the financing arrangement, making it a primary announcement of a capital/financing update rather than just a report publication announcement.
2023-03-02 English
Funding Program between Oxurion and Negma Ends.pdf
Capital/Financing Update Classification · 99% confidence The document is a press release dated March 2, 2023, announcing the termination of a funding program between Oxurion and Negma Group. It details the end of an agreement and provides company background information. Crucially, it does not contain comprehensive financial statements (ruling out 10-K or IR) nor is it a transcript (CT) or a formal notice of dividend (DIV). It is an announcement regarding a corporate/financing event (the end of a funding program), which aligns best with the Capital/Financing Update (CAP) category, as it directly relates to the company's capital structure/funding arrangements. Since the document length is relatively short (3506 chars) and it is a news announcement, CAP is the most specific fit among the primary announcement types.
2023-03-02 English
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from NEGMA (6).pdf
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory announcement from Oxurion NV regarding a change in the total number of voting rights (denominator) following a capital increase from a bond conversion. It explicitly mentions the Belgian Act of May 2, 2007, regarding the disclosure of major participations. While it discusses share capital and voting rights, it is a standard regulatory disclosure announcement rather than a full financial report or a major shareholding notification by an external party. It fits the definition of a regulatory filing (RNS) as it is a formal announcement of corporate changes required by market regulations.
2023-02-24 English
oxur-pr-voting-rights-ned-20230220.pdf
Share Issue/Capital Change Classification · 95% confidence The document is a regulatory announcement from Oxurion NV regarding a change in the total number of voting rights (denominator) following a capital increase resulting from the conversion of convertible bonds. This type of disclosure is a standard regulatory requirement under transparency laws (Article 15 of the Law of 2 May 2007). While it involves a capital change, it is specifically a 'denominator' notification, which is a subset of share capital changes. Given the specific nature of the filing as a regulatory disclosure of voting rights and share counts, it fits best under 'Share Issue/Capital Change' (SHA).
2023-02-24 Dutch

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.